Breaking News

Boeing shares fell on Friday on news that a company technical pilot had raised concerns in 2016 instant messages to a colleague about certain systems on its 737 MAX jet, which were later implicated in two fatal crashes, Al Root writes in this week's edition of Barron's. Boeing turned the information over on Thursday to the Federal Aviation Administration, which said the company had discovered the messages "some months ago." The revelations are the latest "black eye" for the commercial aerospace giant, and also mean more uncertainty for Boeing shareholders, the author contends. Reference Link

GVC Holdings' stock looks like a good bet as the global gambling group positions itself to capitalize on the flourishing U.S. sports betting market, Callum Keown writes in this week's edition of Barron's. The company's geographic and brand diversity, strong online growth, and position in the U.S. mean the stock could continue to rise, the author contends. Reference Link

National Vision has been the fastest growing U.S. optical chain for a decade, with just about every broker calling the stock a Buy, Bill Alpert writes in this week's edition of Barron's. But in recent months, the stock has tumbled as key investor sol shares and shorts started to circle, the author notes. Recent critiques by short-oriented analysts have weighed on the stock, saying that the National Vision's discount offers, widely advertised to low income consumers, are not appropriate for most customers because the material used to make the glasses is too heavy for strong prescriptions and too prone to shattering, Alpert notes. Reference Link

The sector is the second worst performer this year, but the recovery of health stocks might just be starting, after gaining 2% this past week, Ben Levisohn writes in this week's edition of Barron's. The sector benefited from a confluence of factors, including UnitedHealth's (UNH) stronger than expected earnings, reports of a possible opioid settlement that booted pharma companies like Teva Pharmaceuticals (TEVA), and the Democratic debate on Tuesday that provided the first glimmers of hope that Medicare for All might not be the preferred path among the candidates and that large managed-health companies might survive, event if a Democrat wins the 2020 election, the author notes. Other publicly traded companies in the space include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY), Sanofi (SNY), Anthem (ANTM), CVS Health (CVS), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), and WellCare (WCG).Reference Link